Not yet recruiting
Hereditary haemochromatosis
Not yet recruitingA study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis
Investigational
A study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis
Investigational
- Disease:Hereditary haemochromatosis
- Substances:Vamifeport trihydrochloride
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Vamifeport trihydrochloride
- Sponsor:CSL Behring LLC



